$UTI
UNIVERSAL TECHNICAL INSTITUTE INC Stock $uti

$uti Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-K Financial Statement

#000126165420000071 Filed on December 03, 2020

Income Statement

Concept	2020 Q3	2019 Q3	2019 Q2
Revenue	$76.33M	$87.67M	$79.04M
YoY Change	-12.93%	9.23%	5.54%
Cost Of Revenue	$17.10M	$21.20M	$19.90M
YoY Change	-19.34%	-10.17%	-6.13%
Gross Profit	$59.20M	$66.50M	$59.10M
YoY Change	-10.98%	17.28%	10.06%
Gross Profit Margin	77.56%	75.86%	74.77%
Selling, General & Admin	$52.90M	$60.70M	$36.66M
YoY Change	-12.85%	-9.81%	-12.61%
% of Gross Profit	89.36%	91.28%	62.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.980M	$3.270M	$3.340M
YoY Change	-8.87%	4.81%	5.03%
% of Gross Profit	5.03%	4.92%	5.65%
Operating Expenses	$53.10M	$61.00M	$79.50M
YoY Change	-12.95%	-9.9%	-8.3%
Operating Profit	$6.153M	$5.438M	-$455.0K
YoY Change	13.15%	-149.21%	-96.14%
Interest Expense	$200.0K	-$400.0K	$802.0K
YoY Change	-150.0%	0.0%	-300.5%
% of Operating Profit	3.25%	-7.36%
Other Income/Expense, Net	$100.0K	$300.0K	$121.0K
YoY Change	-66.67%	-25.0%	-270.42%
Pretax Income	$6.500M	$5.400M	-$334.0K
YoY Change	20.37%	-149.09%	-97.19%
Income Tax	$100.0K	-$100.0K	$31.00K
% Of Pretax Income	1.54%	-1.85%
Net Earnings	$6.450M	$5.477M	-$365.0K
YoY Change	17.77%	-149.79%	-96.88%
Net Earnings / Revenue	8.45%	6.25%	-0.46%
Basic Earnings Per Share	$0.10	$0.09	-$0.07
Diluted Earnings Per Share	$0.09	$0.09	-$0.07
COMMON SHARES
Basic Shares Outstanding	32.61M shares	25.50M shares	25.50M shares
Diluted Shares Outstanding			25.50M shares

Balance Sheet

Concept	2020 Q3	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$114.9M	$65.40M	$42.70M
YoY Change	75.69%	12.56%	-24.02%
Cash & Equivalents	$76.80M	$65.44M	$42.69M
Short-Term Investments	$38.10M
Other Short-Term Assets	$6.489M	$7.331M	$7.402M
YoY Change	-11.49%	-8.67%	-77.01%
Inventory
Prepaid Expenses	$6.121M	$7.054M	$8.997M
Receivables	$35.41M	$17.94M	$12.03M
Other Receivables	$6.494M	$7.078M	$5.200M
Total Short-Term Assets	$180.2M	$118.1M	$89.80M
YoY Change	52.56%	1.12%	-17.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$217.4M	$104.1M	$106.5M
YoY Change	108.79%	-9.34%	-6.37%
Goodwill	$8.200M	$8.200M	$8.222M
YoY Change	0.0%	-0.27%	0.0%
Intangibles
YoY Change
Long-Term Investments	$4.494M	$4.338M	$4.304M
YoY Change	3.6%	3.14%	3.16%
Other Assets	$8.565M	$10.22M	$9.978M
YoY Change	-16.21%	-8.89%	-10.18%
Total Long-Term Assets	$261.8M	$152.4M	$154.3M
YoY Change	71.76%	-7.89%	-6.77%
TOTAL ASSETS
Total Short-Term Assets	$180.2M	$118.1M	$89.80M
Total Long-Term Assets	$261.8M	$152.4M	$154.3M
Total Assets	$442.0M	$270.5M	$244.1M
YoY Change	63.38%	-4.16%	-10.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.47M	$10.03M	$6.982M
YoY Change	24.3%	14.55%	-14.82%
Accrued Expenses	$11.37M	$13.62M	$11.72M
YoY Change	-16.51%	-14.03%	1.3%
Deferred Revenue	$40.69M	$42.89M
YoY Change	-5.11%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$129.0K	$1.600M	$1.500M
YoY Change	-91.94%	23.08%	15.38%
Total Short-Term Liabilities	$121.6M	$96.84M	$73.99M
YoY Change	25.6%	4.74%	0.99%
LONG-TERM LIABILITIES
Long-Term Debt	$131.0K	$39.20M	$39.60M
YoY Change	-99.67%	-3.69%	-3.65%
Other Long-Term Liabilities	$8.925M	$9.578M	$9.555M
YoY Change	-6.82%	-5.39%	-2.65%
Total Long-Term Liabilities	$9.056M	$9.578M	$9.555M
YoY Change	-5.45%	-5.39%	-2.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$121.6M	$96.84M	$73.99M
Total Long-Term Liabilities	$9.056M	$9.578M	$9.555M
Total Liabilities	$265.5M	$156.2M	$133.4M
YoY Change	69.91%	0.39%	-1.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$32.97M	-$44.67M	-$48.83M
YoY Change	-26.19%	41.57%	153.9%
Common Stock	$141.0M	$187.5M	$188.1M
YoY Change	-24.8%	0.41%	0.92%
Preferred Stock	$68.85M	$68.85M	$68.85M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock (at cost)	$365.0K	$97.39M	$97.39M
YoY Change	-99.63%	0.0%	0.0%
Treasury Stock Shares	82.00K shares	6.865M shares	6.865M shares
Shareholders Equity	$176.5M	$114.3M	$110.7M
YoY Change
Total Liabilities & Shareholders Equity	$442.0M	$270.5M	$244.1M
YoY Change	63.38%	-4.16%	-10.91%

Cashflow Statement

Concept	2020 Q3	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	$6.450M	$5.477M	-$365.0K
YoY Change	17.77%	-149.79%	-96.88%
Depreciation, Depletion And Amortization	$2.980M	$3.270M	$3.340M
YoY Change	-8.87%	4.81%	5.03%
Cash From Operating Activities	$21.15M	$28.87M	-$9.930M
YoY Change	-26.74%	216.9%	-39.41%
INVESTING ACTIVITIES
Capital Expenditures	-$2.070M	-$1.150M	-$520.0K
YoY Change	80.0%	-67.33%	-94.69%
Acquisitions
YoY Change
Other Investing Activities	-$6.500M	$90.00K	$70.00K
YoY Change	-7322.22%	-71.88%	-86.54%
Cash From Investing Activities	-$8.570M	-$1.060M	-$450.0K
YoY Change	708.49%	-66.87%	-95.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.820M	-3.480M	-340.0K
YoY Change	-18.97%	11.18%	21.43%
NET CHANGE
Cash From Operating Activities	21.15M	28.87M	-9.930M
Cash From Investing Activities	-8.570M	-1.060M	-450.0K
Cash From Financing Activities	-2.820M	-3.480M	-340.0K
Net Change In Cash	9.760M	24.33M	-10.72M
YoY Change	-59.88%	775.18%	-58.67%
FREE CASH FLOW
Cash From Operating Activities	$21.15M	$28.87M	-$9.930M
Capital Expenditures	-$2.070M	-$1.150M	-$520.0K
Free Cash Flow	$23.22M	$30.02M	-$9.410M
YoY Change	-22.65%	137.69%	42.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001261654
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85032
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2017	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201409Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesCurrent
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:OtherLiabilitiesNoncurrent
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	1-31923
CY2020	dei	Entity Registrant Name EntityRegistrantName	UNIVERSAL TECHNICAL INSTITUTE, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0226984
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	4225 East Windrose Drive
CY2020	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
CY2020	dei	City Area Code CityAreaCode	623
CY2020	dei	Local Phone Number LocalPhoneNumber	445-9500
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2020	dei	Trading Symbol TradingSymbol	UTI
CY2020	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6121000	USD
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32647362	shares
CY2020Q1	dei	Entity Public Float EntityPublicFloat	170000000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76803000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65442000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12116000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	15113000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38055000	USD
CY2019Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35411000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17937000	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5184000	USD
CY2019Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5227000	USD
CY2019Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7054000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6489000	USD
CY2019Q3	us-gaap	Other Assets Current OtherAssetsCurrent	7331000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	180179000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	118104000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	72743000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104126000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	8222000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	8222000	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	27609000	USD
CY2019Q3	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	29852000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	144663000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8565000	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10222000	USD
CY2020Q3	us-gaap	Assets Assets	441981000	USD
CY2019Q3	us-gaap	Assets Assets	270526000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	51891000	USD
CY2019Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45878000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	40694000	USD
CY2019Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	42886000	USD
CY2020Q3	uti	Accrued Tool Sets AccruedToolSets	3148000	USD
CY2019Q3	uti	Accrued Tool Sets AccruedToolSets	2586000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23666000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	1554000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2241000	USD
CY2019Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3940000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	121640000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	96844000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	674000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	329000	USD
CY2019Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	10326000	USD
CY2019Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	39161000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134089000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9056000	USD
CY2019Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9578000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	265459000	USD
CY2019Q3	us-gaap	Liabilities Liabilities	156238000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32730000	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32499000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32647000	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25634000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2019Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000	shares
CY2019Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000	shares
CY2020Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100
CY2019Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020	us-gaap	Interest Expense InterestExpense	10000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3220000	USD
CY2018	us-gaap	Interest Expense InterestExpense	3310000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	141002000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	187493000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	68853000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	68853000	USD
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	82000	shares
CY2019Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	6865000	shares
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	365000	USD
CY2019Q3	us-gaap	Treasury Stock Value TreasuryStockValue	97388000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32971000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44673000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	176522000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	114288000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441981000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	270526000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300761000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331504000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7665000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	399000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	385000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1467000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1078000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1277000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	137000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-422000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2594000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	316965000	USD
CY2020	uti	Educational Services And Facilities EducationalServicesAndFacilities	155932000	USD
CY2019	uti	Educational Services And Facilities EducationalServicesAndFacilities	178317000	USD
CY2018	uti	Educational Services And Facilities EducationalServicesAndFacilities	182589000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	148700000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	160989000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	169651000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	304632000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	339306000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	352240000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-7802000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-35275000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1152000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	1491000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	1425000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35697000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3015000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-32682000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5264000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2744000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13118000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37932000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.51
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25115000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30113000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25438000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25115000	shares
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	125776000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-32682000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	223000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1815000	USD
CY2018	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5250000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	126645000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	629000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1390000	USD
CY2019	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5250000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	114288000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	698000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2077000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49153000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5264000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	176522000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-32682000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11804000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13222000	USD
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13006000	USD
CY2019	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	2682000	USD
CY2018	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	2682000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	24273000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1164000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1767000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1166000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1511000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2077000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1390000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1815000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2812000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	399000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	385000	USD
CY2020	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	541000	USD
CY2019	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	302000	USD
CY2018	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	33000	USD
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	52000	USD
CY2019	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-561000	USD
CY2018	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-122000	USD
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13749000	USD
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1483000	USD
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2695000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-2286000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-1298000	USD
CY2018	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-3393000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1016000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3157000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1584000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	76000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1016000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	116000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7020000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2942000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3858000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2192000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4650000	USD
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5663000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-6989000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	166000	USD
CY2018	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-812000	USD
CY2020	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-1863000	USD
CY2019	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-300000	USD
CY2018	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-1014000	USD
CY2020	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	0	USD
CY2019	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	-1677000	USD
CY2018	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	5116000	USD
CY2020	uti	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25617000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	739000	USD
CY2019	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	321000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20606000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	64000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-318000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11032000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21746000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13353000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9262000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6453000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25000	USD
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	69678000	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2018	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	31289000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	7739000	USD
CY2020	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1566000	USD
CY2018	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	894000	USD
CY2020	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
CY2019	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
CY2018	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	40902000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	325000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	261000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	267000	USD
CY2018	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	291000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45760000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6152000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27132000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49153000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5264000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5250000	USD
CY2018	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5250000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1319000	USD
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1107000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	698000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	629000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	223000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43092000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7198000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6580000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8364000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8396000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7199000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65442000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58104000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50138000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	15113000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	14055000	USD
CY2017Q3	us-gaap	Restricted Cash RestrictedCash	14822000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80555000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72159000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64960000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76803000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65442000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58104000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12116000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	15113000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	14055000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88919000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80555000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72159000	USD
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	113000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	37000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	610000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3220000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	3310000	USD
CY2020	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	985000	USD
CY2019	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	772000	USD
CY2018	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	3240000	USD
CY2020	uti	Depreciationoftrainingequipmentobtainedinexchangeforservices Depreciationoftrainingequipmentobtainedinexchangeforservices	1345000	USD
CY2019	uti	Depreciationoftrainingequipmentobtainedinexchangeforservices Depreciationoftrainingequipmentobtainedinexchangeforservices	1387000	USD
CY2018	uti	Depreciationoftrainingequipmentobtainedinexchangeforservices Depreciationoftrainingequipmentobtainedinexchangeforservices	1386000	USD
CY2020	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	-490000	USD
CY2019	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	316000	USD
CY2018	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	-1042000	USD
CY2019Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	0	USD
CY2018Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	0	USD
CY2018Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	0	USD
CY2020Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	1797000	USD
CY2020	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	16565000	USD
CY2019	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	0	USD
CY2018	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	0	USD
CY2020	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	17184000	USD
CY2019	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	0	USD
CY2018	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	0	USD
CY2020Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	13889000	USD
CY2019Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	0	USD
CY2020	us-gaap	Nature Of Operations NatureOfOperations	Business Description<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Universal Technical Institute, Inc. (“we,” “us” or “our”) is the leading provider of postsecondary education for students seeking careers as professional automotive, diesel, collision repair, motorcycle and marine technicians as measured by total average full-time enrollment and graduates. We also provide programs for welders and computer numeric control (“CNC”) machining technicians. We offer certificate, diploma or degree programs at 12 campuses across the United States under the banner of several well-known brands, including Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute. This excludes the Norwood, Massachusetts campus that was closed on July 31, 2020. We also offer manufacturer specific advanced training (“MSAT”) programs, including student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Founded in 1965, we have provided technical education for more than 55 years and have graduated more than 220,000 technicians. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work closely with over 35 original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals. Revenues generated from our schools consist primarily of tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), as well as from various veterans benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 20 on “Government Regulation and Financial Aid.”</span></div>
CY2020Q3	uti	Number Of Campuses NumberOfCampuses	12	campus
CY2020	uti	Duration Of Technical Education Provided DurationOfTechnicalEducationProvided	P55Y
CY2020Q3	uti	Number Of Graduated Technicians NumberOfGraduatedTechnicians	220000	technician
CY2020Q3	uti	Number Of Manufacturer Brand Partners And Employers NumberOfManufacturerBrandPartnersAndEmployers	35	plan
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and assumptions, including those related to revenue recognition, our proprietary loan program, allowance for uncollectible accounts, investments, property and equipment, goodwill recoverability, self-insurance claim liabilities, income taxes, contingencies and stock-based compensation. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The results of our analysis form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and the impact of such differences may be material to our consolidated financial statements.</span></div>
CY2020	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.99
CY2019	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.99
CY2018	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.98
CY2020	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2020	us-gaap	Loan Processing Fee LoanProcessingFee	900000	USD
CY2019	us-gaap	Loan Processing Fee LoanProcessingFee	1100000	USD
CY2018	us-gaap	Loan Processing Fee LoanProcessingFee	1300000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	8200000	USD
CY2020Q3	uti	Increase Decrease In Average Student Enrollment IncreaseDecreaseInAverageStudentEnrollment	-0.038
CY2020Q3	uti	Increase Decrease In New Student Enrollment IncreaseDecreaseInNewStudentEnrollment	0.034
CY2020Q3	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	3400000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	39700000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	41200000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	44800000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1400000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	400000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, short-term investments and receivables. As of September 30, 2020, we held cash and cash equivalents of $76.8 million, restricted cash of $12.1 million and short-term held-to-maturity investments of $38.1 million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We place our cash and cash equivalents and restricted cash with high quality financial institutions and limit the amount of credit exposure with any one financial institution. We mitigate the concentration risk of our investments by limiting the amount invested in any one issuer. We mitigate the risk associated with our investment in corporate bonds by requiring a minimum credit rating of A. We have the ability and intention to hold these investments until maturity and therefore have classified these investments as held-to-maturity and recorded them at amortized cost.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We extend credit for tuition and fees, for a limited period of time, to a majority of our students. A substantial portion is repaid through the student’s participation in federally funded financial aid programs. Transfers of funds from the financial aid programs to us are made in accordance with the ED requirements. Approximately 66% of our revenues, on a cash basis, were collected from funds distributed under Title IV Programs for the year ended September 30, 2020 as calculated under the 90/10 rule. Additionally, approximately 17% of our revenues, on a cash basis, were collected from funds distributed under various veterans benefits programs for the year ended September 30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial aid and veterans benefits programs are subject to political and budgetary considerations. There is no assurance that such funding will be maintained at current levels. Extensive and complex regulations govern the financial assistance programs in which our students participate. Our administration of these programs is periodically reviewed by various regulatory agencies. Any regulatory violation could be the basis for the initiation of potential adverse actions, including a suspension, limitation, placement on reimbursement status or termination proceeding, which could have a material adverse effect on our business. ED and other regulators have increased the frequency and severity of their enforcement actions against postsecondary schools which have resulted in the imposition of material liabilities, sanctions, letter of credit requirements and other restrictions and, in some cases, resulted in the loss of schools’ eligibility to receive Title IV funds or in closure of the schools. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our institutions were to lose its eligibility to participate in federal student financial aid programs, the students at that institution would lose access to funds derived from those programs and would have to seek alternative sources of funds to pay their tuition and fees. Students obtain access to federal student financial aid through an ED prescribed application and eligibility certification process. Student financial aid funds are generally made available to students at prescribed intervals throughout their predetermined expected length of study. Students typically apply the funds received from the federal financial aid programs to pay their tuition and fees. The transfer of funds is from the financial aid program to the student, who then uses those funds to pay for a portion of the cost of their education. The receipt of financial aid funds reduces the student’s amounts due to us and has no impact on revenue recognition, as the transfer relates to the source of funding for the costs of education, which may occur either through Title IV or other funds and resources available to the student.</span></div>
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76800000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12100000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38100000	USD
CY2020	uti	Percentage Of Cash Basis Revenue Collected From Funds Distributed Under Title Iv Programs PercentageOfCashBasisRevenueCollectedFromFundsDistributedUnderTitleIvPrograms	0.66
CY2020	uti	Percentageof Cash Basis Revenue Collectedfrom Funds Distributed Under Veterans Benefits Programs PercentageofCashBasisRevenueCollectedfromFundsDistributedUnderVeteransBenefitsPrograms	0.17
CY2020	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	Recent Accounting Pronouncements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Effective in Fiscal 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2016-02”), which amended the FASB Accounting Standards Codification (“ASC”) by creating ASC 842 to replace ASC 840. ASU 2016-02 requires lessees to recognize a right-of-use (“ROU”) asset and a lease liability on the balance sheet for substantially all leases, with the exception of short-term leases. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the statement of income. In July 2018, the FASB issued ASU 2018-11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to provide entities with relief from the costs of implementing certain aspects of the new leasing standard. It also allows lessors to elect not to separate lease and non-lease components when certain conditions are met. In March 2019, the FASB issued ASU 2019-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lease (Topic 842): Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2019-01”). ASU 2019-01 clarifies certain items regarding lessor accounting. It also clarifies the interim disclosure requirements during transition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new guidance in ASC 842 also provides a package of transition practical expedients that allow an entity to not reassess (1) whether any expired or existing contracts contain a lease, (2) the lease classification of any expired or existing lease, and (3) initial direct costs for any existing lease. We adopted ASC 842 effective October 1, 2019, and elected the package of transition practical expedients. We also elected additional transitional practical expedients that allow an entity to not reassess land easements not previously addressed under ASC 840 and to not recognize on the balance sheet leases with terms of less than 12 months. We are using the modified retrospective method without the recasting of comparative periods’ financial information. We did not elect the practical expedient to use hindsight in determining a lease term of the ROU assets at the adoption date. As a result of adopting the new standard, we recognized an operating lease liability of $163.0 million and an operating lease ROU asset of $148.6 million on October 1, 2019. The change resulted in the de-recognition of approximately $0.9 million of other assets and $15.3 million of other liabilities. The standard did not materially impact our condensed consolidated statements of operations and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have two build-to-suit leases that were accounted for as financing obligations and related assets because we had continued involvement in the related facility after the construction period was completed. The financing obligations are now classified as operating leases in accordance with the new standard as of the transition date, including recognition of operating lease ROU assets and lease liabilities. The change resulted in the de-recognition of approximately $40.7 million existing deferred financing obligations and $31.6 million in related assets. The net impact of the de-recognition and the adoption of ASC 842 as of October 1, 2019 was an increase in stockholders’ equity of approximately $9.1 million, with a subsequent adjustment during the three months ended March 31, 2020, which reduced the impact to stockholders’ equity by $0.1 million. The transition also resulted in the recognition of rent expense, which was previously reported as interest expense under the former guidance. See Note 10 “Leases” for our fiscal 2020 disclosures. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2018-13”). ASU 2018-13 amends the disclosure requirements of ASC 820, changing the fair value measurement disclosure requirements of ASC 820 by adding new disclosure requirements, modifying existing disclosure requirements and eliminating other disclosure requirements. We adopted ASU 2018-13 as of October 1, 2019. There was no impact to our consolidated financial statements or disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cloud Computing Arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles—Goodwill and other Internal-use Software (Subtopic 350-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2018-15”). ASU 2018-15 aligns the accounting for costs incurred to implement a cloud computing arrangement (“CCA”) that is a service arrangement with the guidance on capitalizing costs associated with developing or obtaining internal-use software. Specifically, ASU 2018-15 amends ASC 350 to include in its scope implementation costs of a CCA that is a service contract and clarifies that a customer should apply ASC 350-40 to determine which implementation costs </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">should be capitalized in a CCA that is considered a service contract. The effect of this new standard on our consolidated financial statements is dependent on our entry into any future cloud computing arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Effective in Fiscal 2021</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments—Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update significantly changes the way that entities will be required to measure credit losses. This standard requires that entities estimate credit losses based upon an “expected credit loss” approach rather than the “incurred loss” approach, which is currently used. The new approach will require entities to measure all expected credit losses for financial assets based on historical experience, current conditions and reasonable forecasts of collectability. The change in approach is anticipated to impact the timing of recognition of credit losses. This standard is effective for financial statements issued by public companies for annual and interim periods beginning after December 15, 2019. These changes became effective for the Company's fiscal year beginning October 1, 2020. Upon adoption on October 1, 2020, we recorded an increase in our receivables balance related to our proprietary loan program of $1.6 million, with the corresponding amount recorded as an increase to retained earnings. No other adjustments were deemed necessary in applying this new guidance, and we do not expect the adoption of ASU 2016-13 to have a material impact on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Effective in Fiscal 2022</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2019-12”). The amendments in ASU 2019-12 simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. We are currently evaluating the impact that the update will have on our results of operations, financial condition and financial statement disclosures.</span></div>
CY2020Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	53144000	USD
CY2019Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	44629000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	40694000	USD
CY2019Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	42886000	USD
CY2020Q1	uti	Number Of Online Students NumberOfOnlineStudents	8000	student
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	8	campus
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	4	campus
CY2020Q3	uti	Students Not Returned To Campus Percentage StudentsNotReturnedToCampusPercentage	0.05
CY2020Q3	uti	Students Completing Catch Up Labs Percentage StudentsCompletingCatchUpLabsPercentage	0.28
CY2020Q3	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	1100000	USD
CY2018Q3	us-gaap	Postemployment Benefits Liability Current And Noncurrent PostemploymentBenefitsLiabilityCurrentAndNoncurrent	381000	USD
CY2019	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	1727000	USD
CY2019	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	1187000	USD
CY2019	uti	Post Employment Benefits Other Non Cash Settlement Increase Decrease PostEmploymentBenefitsOtherNonCashSettlementIncreaseDecrease	-168000	USD
CY2019Q3	us-gaap	Postemployment Benefits Liability Current And Noncurrent PostemploymentBenefitsLiabilityCurrentAndNoncurrent	753000	USD
CY2020	us-gaap	Postemployment Benefits Period Expense PostemploymentBenefitsPeriodExpense	2280000	USD
CY2020	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	2261000	USD
CY2020	uti	Post Employment Benefits Other Non Cash Settlement Increase Decrease PostEmploymentBenefitsOtherNonCashSettlementIncreaseDecrease	102000	USD
CY2020Q3	us-gaap	Postemployment Benefits Liability Current And Noncurrent PostemploymentBenefitsLiabilityCurrentAndNoncurrent	874000	USD
CY2020Q3	uti	Tuition Receivables TuitionReceivables	23565000	USD
CY2019Q3	uti	Tuition Receivables TuitionReceivables	11800000	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	7145000	USD
CY2019Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	156000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	579000	USD
CY2020Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6494000	USD
CY2019Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	7078000	USD
CY2020Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37204000	USD
CY2019Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	19034000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1793000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1097000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35411000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17937000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1097000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	999000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1767000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1166000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1511000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1071000	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1068000	USD
CY2018	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1091000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1793000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1097000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	999000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49500000	USD
CY2020Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	38055000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	10000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	33000	USD
CY2020Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	38032000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	359000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	255106000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	305657000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	182363000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	201531000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	72743000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104126000	USD
CY2019Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	45816000	USD
CY2019Q3	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	14208000	USD
CY2019Q3	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	31608000	USD
CY2020	uti	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	10	location
CY2020Q3	uti	Number Of Campuses NumberOfCampuses	12	location
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	29348000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	102000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	4120000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	744000	USD
CY2020	us-gaap	Lease Cost LeaseCost	32833000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	144663000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	257000	USD
CY2020Q3	uti	Lease Right Of Use Asset LeaseRightOfUseAsset	144920000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23666000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	129000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134089000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	131000	USD
CY2020Q3	uti	Lease Liability LeaseLiability	158015000	USD
CY2020Q3	uti	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	100000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	25617000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20321000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	215000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M2D
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y18D
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0437
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0308
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	28212000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	135000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	27447000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	110000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	18565000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	23000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	17435000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15022000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	86134000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	192815000	USD
CY2020Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	268000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	35060000	USD
CY2020Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	8000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	157755000	USD
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	260000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23666000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	129000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134089000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	131000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Remainder Of Fiscal Year Gross OperatingLeasesFutureMinimumPaymentsDueRemainderOfFiscalYearGross	26379000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear	362000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Gross Total OperatingLeasesFutureMinimumPaymentsDueGrossTotal	132994000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	26017000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due In Year One Gross OperatingLeasesFutureMinimumPaymentsDueInYearOneGross	23531000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Year One OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInYearOne	77000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	23454000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due In Year Two Gross OperatingLeasesFutureMinimumPaymentsDueInYearTwoGross	21621000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Year Two OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInYearTwo	78000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	21543000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due In Year Three Gross OperatingLeasesFutureMinimumPaymentsDueInYearThreeGross	10461000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Year Three OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInYearThree	20000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	10441000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due In Year Four Gross OperatingLeasesFutureMinimumPaymentsDueInYearFourGross	9180000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Year Four OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInYearFour	0	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9180000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due After Year Four Gross OperatingLeasesFutureMinimumPaymentsDueAfterYearFourGross	41822000	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due After Year Four OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueAfterYearFour	0	USD
CY2019Q3	uti	Operating Leases Future Minimum Payments Due After Four Years OperatingLeasesFutureMinimumPaymentsDueAfterFourYears	41822000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	537000	USD
CY2019Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	132457000	USD
CY2020	uti	Operating Leases Rent Expense Paid To Related Parties OperatingLeasesRentExpensePaidToRelatedParties	2000000.0	USD
CY2020	uti	Minimum Annual Rent Increase MinimumAnnualRentIncrease	0.04
CY2012Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4000000.0	USD
CY2012Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.28
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4338000	USD
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4206000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	261000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	267000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4494000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4338000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12471000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	10033000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28053000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22230000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11367000	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13615000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	51891000	USD
CY2019Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45878000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-11250000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2000	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-125000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	303000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	205000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-78000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-10947000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	203000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-203000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2878000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	66000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2812000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3015000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-545000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1610000	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-8746000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	246000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	165000	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-12000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	12645000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6135000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1514000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7066000	USD
CY2020	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	-4270000	USD
CY2019	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	0	USD
CY2018	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	0	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	102000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	134000	USD
CY2018	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	164000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2665000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	0	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3015000	USD
CY2020Q3	uti	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	40515000	USD
CY2019Q3	uti	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	0	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	802000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1449000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	3940000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2432000	USD
CY2020Q3	uti	Deferred Tax Assets Tax Deferred Expense Accrued Tool Sets DeferredTaxAssetsTaxDeferredExpenseAccruedToolSets	831000	USD
CY2019Q3	uti	Deferred Tax Assets Tax Deferred Expense Accrued Tool Sets DeferredTaxAssetsTaxDeferredExpenseAccruedToolSets	694000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1884000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4406000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4324000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	3024000	USD
CY2020Q3	uti	Deferred Tax Assets Financing Obligation DeferredTaxAssetsFinancingObligation	0	USD
CY2019Q3	uti	Deferred Tax Assets Financing Obligation DeferredTaxAssetsFinancingObligation	10178000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6729000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12639000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	293000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	205000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	1527000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	1234000	USD
CY2020Q3	uti	Deferred Tax Assets Deductions Limited By Section382 DeferredTaxAssetsDeductionsLimitedBySection382	764000	USD
CY2019Q3	uti	Deferred Tax Assets Deductions Limited By Section382 DeferredTaxAssetsDeductionsLimitedBySection382	670000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17449000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25673000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	45023000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13060000	USD
CY2020Q3	uti	Deferred Tax Liabilities Operating Lease Liability DeferredTaxLiabilitiesOperatingLeaseLiability	37083000	USD
CY2019Q3	uti	Deferred Tax Liabilities Operating Lease Liability DeferredTaxLiabilitiesOperatingLeaseLiability	0	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2056000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2056000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5547000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	10470000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1011000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	863000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	45697000	USD
CY2019Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13389000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	674000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	329000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17400000	USD
CY2019Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25700000	USD
CY2019Q3	uti	Operating Loss Carryback Cares Act OperatingLossCarrybackCARESAct	20300000	USD
CY2020	uti	Deferred Compensation Arrangement Maximum Contribution Per Employee Percentage Of Regular Compensation DeferredCompensationArrangementMaximumContributionPerEmployeePercentageOfRegularCompensation	0.75
CY2018Q3	uti	Operating Loss Carryback Cares Act OperatingLossCarrybackCARESAct	13000000.0	USD
CY2018	uti	Proceeds From Income Tax Refunds Cares Act ProceedsFromIncomeTaxRefundsCARESAct	11300000	USD
	uti	Proceeds From Income Tax Refunds Cares Act ProceedsFromIncomeTaxRefundsCARESAct	11300000	USD
CY2020	uti	Proceeds From Income Tax Refunds Cares Act ProceedsFromIncomeTaxRefundsCARESAct	4200000	USD
CY2020Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	7100000	USD
CY2015Q2	uti	Licensing Agreement Initial Term LicensingAgreementInitialTerm	P4Y
CY2015Q2	uti	Licensing Agreement Number Of Renewal Options LicensingAgreementNumberOfRenewalOptions	3	option
CY2015Q2	uti	Licensing Agreement Term LicensingAgreementTerm	P7Y
CY2015Q2	uti	Licensing Agreement Term LicensingAgreementTerm	P7Y
CY2020	uti	Maximum License Costs Over Term MaximumLicenseCostsOverTerm	2300000	USD
CY2020Q3	uti	Net Prepaid Expenses From Excess Of Credits Earned Over Credits Used NetPrepaidExpensesFromExcessOfCreditsEarnedOverCreditsUsed	5500000	USD
CY2019Q3	uti	Net Prepaid Expenses From Excess Of Credits Earned Over Credits Used NetPrepaidExpensesFromExcessOfCreditsEarnedOverCreditsUsed	6400000	USD
CY2020Q3	uti	Accrued Tool Sets AccruedToolSets	3100000	USD
CY2019Q3	uti	Accrued Tool Sets AccruedToolSets	2600000	USD
CY2020Q3	uti	Liability To Vendor For Vouchers Redeemed By Students LiabilityToVendorForVouchersRedeemedByStudents	1900000	USD
CY2019Q3	uti	Liability To Vendor For Vouchers Redeemed By Students LiabilityToVendorForVouchersRedeemedByStudents	2100000	USD
CY2020	uti	Deferred Compensation Arrangement Maximum Contribution Per Employee Percentage Of Incentive Compensation DeferredCompensationArrangementMaximumContributionPerEmployeePercentageOfIncentiveCompensation	1
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	210000	shares
CY2020	uti	Deferred Compensation Arrangement With Individual Maximum Annual Deferrals Of Cash Compensation Per Individual Percent DeferredCompensationArrangementWithIndividualMaximumAnnualDeferralsOfCashCompensationPerIndividualPercent	1
CY2020	uti	Deferred Compensation Arrangement With Individual Vesting Period DeferredCompensationArrangementWithIndividualVestingPeriod	P5Y
CY2020Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3000000.0	USD
CY2019Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	4300000	USD
CY2020Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	3300000	USD
CY2019Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	4800000	USD
CY2020Q3	uti	Common Stock Shareholder Number Of Votes CommonStockShareholderNumberOfVotes	1	vote
CY2016Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1200000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5300000	USD
CY2019	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5300000	USD
CY2020Q3	uti	Ownership Number Of Affiliated Holders OwnershipNumberOfAffiliatedHolders	6	holder
CY2020Q3	uti	Ownership Number Of Unaffiliated Holders OwnershipNumberOfUnaffiliatedHolders	12	holder
CY2020Q3	uti	Affiliated Holder Preferred Stock Convertible Conversion Cap AffiliatedHolderPreferredStockConvertibleConversionCap	P180D
CY2020Q3	uti	Preferred Stock Convertible Volume Weighted Average Price Rate PreferredStockConvertibleVolumeWeightedAveragePriceRate	2.5
CY2020	uti	Preferred Stock Convertible Consecutive Trading Days PreferredStockConvertibleConsecutiveTradingDays	20	day
CY2020	uti	Preferred Stock Convertible Conversion Cap PreferredStockConvertibleConversionCap	P120D
CY2020	uti	Preferred Stock Convertible Notice Of Conversion PreferredStockConvertibleNoticeOfConversion	P10D
CY2020Q3	uti	Preferred Stock Convertible Volume Weighted Average Price Rate PreferredStockConvertibleVolumeWeightedAveragePriceRate	2.5
CY2020	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	1609000	USD
CY2019	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-13118000	USD
CY2018	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-37932000	USD
CY2020	uti	Preferred Stock Convertible Notice Of Conversion PreferredStockConvertibleNoticeOfConversion	P10D
CY2020Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	49200000	USD
CY2011Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000.0	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1677570	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.09
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	15300000	USD
CY2020Q3	uti	Share Based Payment Arrangement Number Of Plans ShareBasedPaymentArrangementNumberOfPlans	2	plan
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2077000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1440000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1864000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	519000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	360000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	466000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	210000	shares
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	210000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.14
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M8D
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	483000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	0	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	210000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	407000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	210000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.14
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M4D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	407000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-32682000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5264000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2744000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13118000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37932000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1135000	USD
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2018	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2017Q4	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1400000	USD
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25115000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.51
CY2020	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	1609000	USD
CY2019	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-13118000	USD
CY2018	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-37932000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25115000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	301000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30113000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25438000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25115000	shares
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21035000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21754000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21355000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	51134000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	46971000	shares
CY2018	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	46382000	shares
CY2018	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	15688000	USD
CY2019	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000.0	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000.0	USD
CY2018	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000.0	USD
CY2020Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	13900000	USD
CY2020	uti	Total Institutional Funds Spent Cares Act TotalInstitutionalFundsSpentCARESAct	15700000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300761000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	USD
CY2020	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	11804000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331504000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-7802000	USD
CY2019	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	15904000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	316965000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-35275000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-32682000	USD
CY2020Q3	us-gaap	Assets Assets	441981000	USD
CY2019Q3	us-gaap	Assets Assets	270526000	USD
CY2020	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1300000	USD
CY2018Q4	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1400000	USD
CY2020	uti	Percentage Of Cash Basis Revenue Collected From Funds Distributed Under Title Iv Programs PercentageOfCashBasisRevenueCollectedFromFundsDistributedUnderTitleIvPrograms	0.66
CY2020	uti	Percentageof Cash Basis Revenue Collectedfrom Funds Distributed Under Veterans Benefits Programs PercentageofCashBasisRevenueCollectedfromFundsDistributedUnderVeteransBenefitsPrograms	0.17
CY2020Q3	uti	Relief Funds To Be Distributed Cares Act ReliefFundsToBeDistributedCARESAct	14000000000.0	USD
CY2020Q3	uti	Relief Funds To Be Distributed Formula Based Amount Cares Act ReliefFundsToBeDistributedFormulaBasedAmountCARESAct	12560000000	USD
CY2020Q2	uti	Amount Granted Cares Act AmountGrantedCARESAct	33000000.0	USD
CY2020Q2	uti	Proceeds Received Cares Act ProceedsReceivedCARESAct	16500000	USD
CY2020Q3	uti	Grants Awarded To Students Amount Cares Act GrantsAwardedToStudentsAmountCARESAct	16500000	USD
CY2020Q3	uti	Number Of Students Awarded Grants Cares Act NumberOfStudentsAwardedGrantsCARESAct	9000	student
CY2020Q2	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	16500000	USD
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	8	campus
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	4	campus
	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Institutional Funds Additional Emergency Grants Cares Act InstitutionalFundsAdditionalEmergencyGrantsCARESAct	600000	USD
CY2020	uti	Total Institutional Funds Spent Cares Act TotalInstitutionalFundsSpentCARESAct	15700000	USD
CY2020Q3	us-gaap	Grants Receivable GrantsReceivable	2700000	USD
CY2020Q3	uti	Receivable Cares Act ReceivableCARESAct	800000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87234000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	82717000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	54483000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	76327000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300761000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	4254000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-499000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-13779000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	6153000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	4684000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	10142000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-13268000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	6450000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	83050000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81746000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	79042000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87666000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331504000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-7205000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5580000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-455000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	5438000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-7802000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-7717000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-5263000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-365000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	5477000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52

Files In Submission

Name	View Source	Status
0001261654-20-000071-index-headers.html	Edgar Link	pending
0001261654-20-000071-index.html	Edgar Link	pending
0001261654-20-000071.txt	Edgar Link	pending
0001261654-20-000071-xbrl.zip	Edgar Link	pending
exhibit211-9302020.htm	Edgar Link	pending
exhibit231-9302020.htm	Edgar Link	pending
exhibit311-9302020.htm	Edgar Link	pending
exhibit312-9302020.htm	Edgar Link	pending
exhibit321-9302020.htm	Edgar Link	pending
exhibit322-9302020.htm	Edgar Link	pending
exhibit46-9302020.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uti-20200930.htm	Edgar Link	pending
uti-20200930.xsd	Edgar Link	pending
uti-20200930_cal.xml	Edgar Link	unprocessable
uti-20200930_def.xml	Edgar Link	unprocessable
uti-20200930_g1.jpg	Edgar Link	pending
uti-20200930_htm.xml	Edgar Link	completed
uti-20200930_lab.xml	Edgar Link	unprocessable
uti-20200930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UTI
UNIVERSAL TECHNICAL INSTITUTE INC Stock $uti

2020 Q3 Form 10-K Financial Statement

#000126165420000071 Filed on December 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTI UNIVERSAL TECHNICAL INSTITUTE INC Stock $uti

2020 Q3 Form 10-K Financial Statement

#000126165420000071 Filed on December 03, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTI
UNIVERSAL TECHNICAL INSTITUTE INC Stock $uti